All posts by Alzforum, Gwyneth Dickey Zakaib

CRISPR Verifies Risk Alleles, Improves Gene Editing

New versions of the CRISPR/Cas9 gene-editing system allow researchers to alter the eukaryotic genome more precisely and efficiently than ever before. First used on the mammalian genome in 2013, CRISPR is continually being improved and is now being used to study neurodegenerative disease. In the April 20 issue of Nature, scientists led by Rudolf Jaenisch […]

Read more »